X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs ABBOTT INDIA - Comparison Results

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS ABBOTT INDIA DR. DATSONS LABS/
ABBOTT INDIA
 
P/E (TTM) x -10.9 35.2 - View Chart
P/BV x 0.2 10.2 1.6% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 DR. DATSONS LABS   ABBOTT INDIA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
ABBOTT INDIA
Mar-17
DR. DATSONS LABS/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs1265,190 2.4%   
Low Rs314,351 0.7%   
Sales per share (Unadj.) Rs133.01,382.9 9.6%  
Earnings per share (Unadj.) Rs0.2130.2 0.1%  
Cash flow per share (Unadj.) Rs6.6137.9 4.8%  
Dividends per share (Unadj.) Rs040.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs128.8652.7 19.7%  
Shares outstanding (eoy) m31.6621.25 149.0%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.63.4 17.1%   
Avg P/E ratio x516.136.6 1,408.5%  
P/CF ratio (eoy) x11.834.6 34.2%  
Price / Book Value ratio x0.67.3 8.3%  
Dividend payout %030.7 0.0%   
Avg Mkt Cap Rs m2,477101,373 2.4%   
No. of employees `000NA3.1 0.0%   
Total wages/salary Rs m563,453 1.6%   
Avg. sales/employee Rs ThNM9,531.9-  
Avg. wages/employee Rs ThNM1,119.9-  
Avg. net profit/employee Rs ThNM897.3-  
INCOME DATA
Net Sales Rs m4,21129,387 14.3%  
Other income Rs m79576 13.7%   
Total revenues Rs m4,28929,963 14.3%   
Gross profit Rs m5693,973 14.3%  
Depreciation Rs m204164 124.4%   
Interest Rs m43020 2,108.8%   
Profit before tax Rs m134,365 0.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m61,598 0.4%   
Profit after tax Rs m52,767 0.2%  
Gross profit margin %13.513.5 99.9%  
Effective tax rate %48.036.6 131.2%   
Net profit margin %0.19.4 1.2%  
BALANCE SHEET DATA
Current assets Rs m6,85218,906 36.2%   
Current liabilities Rs m6,7116,297 106.6%   
Net working cap to sales %3.342.9 7.8%  
Current ratio x1.03.0 34.0%  
Inventory Days Days16162 258.7%  
Debtors Days Days31822 1,471.8%  
Net fixed assets Rs m3,6731,159 317.0%   
Share capital Rs m317213 149.0%   
"Free" reserves Rs m3,76113,657 27.5%   
Net worth Rs m4,07813,869 29.4%   
Long term debt Rs m1,6710-   
Total assets Rs m12,63320,638 61.2%  
Interest coverage x1.0215.0 0.5%   
Debt to equity ratio x0.40-  
Sales to assets ratio x0.31.4 23.4%   
Return on assets %3.413.5 25.5%  
Return on equity %0.119.9 0.6%  
Return on capital %7.731.6 24.3%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m9640-   
Fx outflow Rs m6070-   
Net fx Rs m3570-   
CASH FLOW
From Operations Rs m1,3453,072 43.8%  
From Investments Rs m-2,256-1,554 145.1%  
From Financial Activity Rs m-1,200-898 133.7%  
Net Cashflow Rs m-2,111621 -340.2%  

Share Holding

Indian Promoters % 4.5 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 0.0 7.9 -  
FIIs % 1.4 0.1 1,350.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 17.1 550.3%  
Shareholders   20,807 18,270 113.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   PLETHICO PHARMA  BIOCON LTD  J.B.CHEMICALS  NATCO PHARMA  AJANTA PHARMA  

Compare DR. DATSONS LABS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Extends Losses; Pharma Stocks Top Losers(Closing)

After opening the day in red share markets in India witnessed negative trading activity throughout the day, and ended well below the dotted line.

Related Views on News

Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)

Mar 14, 2018

Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?

Bharat Dynamics IPO: Worth Betting on Defence Manufacturing? (IPO)

Mar 12, 2018

Should you apply for the IPO of Bharat Dynamics, India's first state-owned missile manufacturer?

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

Khadim India Ltd. (IPO)

Oct 31, 2017

Should you subscribe to the IPO of Khadim India Ltd?

Mahindra Logistics Ltd. (IPO)

Oct 28, 2017

Should you subscribe to the IPO of Mahindra Logistics Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Looking Beyond the Colourful Prism of This Airline Company(Sector Info)

May 10, 2018

Can Interglobe Aviation Safely Fly Out of Turbulence?

HDFC Prudence Fund Now HDFC Balanced Advantage Fund - Time To Sell?(Outside View)

May 9, 2018

PersonalFN provides detail analysis on HDFC Balanced Advantage Fund (erstwhile HDFC Prudence Fund and HDFC Growth Fund).

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS